To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.

119 HR 1142 IH: To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes. U.S. House of Representatives 2025-02-07 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 1142 IN THE HOUSE OF REPRESENTATIVES February 7, 2025 Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes. 1. Establishment of drug adherence guidelines Title XVII of the Public Health Service Act ( 42 U.S.C. 300u et seq. ) is amended by inserting after section 1711 ( 42 U.S.C. 300u–16 ) the following: 1712. Establishment of drug adherence guidelines (a) In general The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs. (b) Contents In establishing the guidelines under subsection (a), the Secretary shall— (1) incorporate artificial intelligence and machine learning technologies; and (2) to the maximum extent practicable, promote the use of generic and biosimilar drugs. (c) Definitions In this section: (1) Medicare part b drug The term Medicare part B drug means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act ( 42 U.S.C. 1395j et seq. ). (2) Medicare part d drug The term Medicare part D drug means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act ( 42 U.S.C. 1395w–102(e) )). .